These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 36534424)
1. Expanding the spectrum of "mesenchymal" tumors of the central nervous system. Pizzimenti C; Gianno F; Gessi M Pathologica; 2022 Dec; 114(6):455-464. PubMed ID: 36534424 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities. Tauziède-Espariat A; Hasty L; Métais A; Varlet P Acta Neuropathol Commun; 2023 Feb; 11(1):22. PubMed ID: 36737790 [TBL] [Abstract][Full Text] [Related]
4. [Mesenchymal and Non-meningothelial Tumors Involving the Central Nervous System]. Oya S; Murakami C No Shinkei Geka; 2023 Sep; 51(5):837-844. PubMed ID: 37743335 [TBL] [Abstract][Full Text] [Related]
5. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue. Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988 [TBL] [Abstract][Full Text] [Related]
6. Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patients. Diaz Coronado RY; Mynarek M; Koelsche C; Mora Alferez P; Casavilca Zambrano S; Wachtel Aptowitzer A; Sahm F; von Deimling A; Schüller U; Spohn M; Sturm D; Pfister SM; Morales La Madrid A; Sernaque Quintana R; Sarria Bardales G; Negreiros Chinchihuara T; Ojeda Medina L; Garcia-Corrochano Medina P; Campos Sanchez DA; Ponce Farfan J; Rutkowski S; Garcia Leon JL Cancer; 2022 Feb; 128(4):697-707. PubMed ID: 34674226 [TBL] [Abstract][Full Text] [Related]
8. Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions. Gojo J; Kjaersgaard M; Zezschwitz BV; Capper D; Tietze A; Kool M; Haberler C; Pizer B; Hoff KV Eur J Med Genet; 2023 Jan; 66(1):104660. PubMed ID: 36356895 [TBL] [Abstract][Full Text] [Related]
9. CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors. Barresi V; Cardoni A; Miele E; Pedace L; Masotto B; Nardini C; Barresi S; Rossi S Acta Neuropathol Commun; 2024 Jan; 12(1):8. PubMed ID: 38216991 [TBL] [Abstract][Full Text] [Related]
10. BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas. Kao YC; Owosho AA; Sung YS; Zhang L; Fujisawa Y; Lee JC; Wexler L; Argani P; Swanson D; Dickson BC; Fletcher CDM; Antonescu CR Am J Surg Pathol; 2018 May; 42(5):604-615. PubMed ID: 29300189 [TBL] [Abstract][Full Text] [Related]
11. Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma. Santiago T; Clay MR; Allen SJ; Orr BA Mod Pathol; 2017 Jun; 30(6):884-891. PubMed ID: 28256570 [TBL] [Abstract][Full Text] [Related]
13. Embryonal tumors in the WHO CNS5 classification: A Review. Gianno F; Miele E; Antonelli M; Giangaspero F Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137 [TBL] [Abstract][Full Text] [Related]
14. Primary bone sarcoma with BCOR internal tandem duplication. Malik F; Zreik RT; Hedges DJ; Nakitandwe J; Lee S; Ward RA; McCarville MB; Pappo A; Bahrami A Virchows Arch; 2020 Jun; 476(6):915-920. PubMed ID: 31900635 [TBL] [Abstract][Full Text] [Related]
15. Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft Tissues. Argani P; Kao YC; Zhang L; Bacchi C; Matoso A; Alaggio R; Epstein JI; Antonescu CR Am J Surg Pathol; 2017 Dec; 41(12):1702-1712. PubMed ID: 28817404 [TBL] [Abstract][Full Text] [Related]
16. A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes. Tauziède-Espariat A; Pierron G; Guillemot D; Sievers P; Cazals-Hatem D; Faillot T; Roux A; Benzakoun J; Bockel S; Weinbreck N; Hasty L; Lechapt E; Chrétien F; Varlet P Acta Neuropathol Commun; 2021 Oct; 9(1):174. PubMed ID: 34715942 [TBL] [Abstract][Full Text] [Related]
17. Central nervous system sarcoma with ATXN1::DUX4 fusion expands the concept of CIC-rearranged sarcoma. Satomi K; Ohno M; Kubo T; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Ichikawa H; Yoshida A Genes Chromosomes Cancer; 2022 Nov; 61(11):683-688. PubMed ID: 35715887 [TBL] [Abstract][Full Text] [Related]
18. Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant. Alexandrescu S; Meredith DM; Lidov HG; Alaggio R; Novello M; Ligon KL; Vargas SO Histopathology; 2021 Jan; 78(2):265-275. PubMed ID: 32692439 [TBL] [Abstract][Full Text] [Related]
19. Central nervous system tumors of uncertain differentiation. A Jacobo J World Neurosurg X; 2024 Apr; 22():100349. PubMed ID: 38455248 [TBL] [Abstract][Full Text] [Related]
20. Some CNS sarcomas seen: A 22-year series. Kleinschmidt-DeMasters BK; Gilani A Clin Neuropathol; 2023; 42(2):54-65. PubMed ID: 36708209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]